ReviewTherapeutic advances in infectious disease
The interplay between chronic kidney disease and urinary tract infections: a comprehensive review on the pathophysiological insights, interconnected burdens, and prevention strategies.
Review in Therapeutic advances in infectious disease. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Urinary tract infections (UTIs) and chronic kidney disease (CKD) contribute to a substantial global health issue that is closely intertwined. Research has demonstrated that CKD increases the likelihood of individuals experiencing frequent, severe, and often antibiotic-resistant UTIs, which can accelerate the diminution of kidney function and result in end-stage kidney disease. The inherent structural, metabolic, and immunological disruptions linked to CKD create a suitable environment for uropathogens to grow in the urinary tract. This risk is further heightened by ongoing exposure to antibiotics, which facilitates the emergence of multidrug-resistant (MDR) organisms, complicating treatment options. This review discusses the existing literature on the clinical and microbiological relationship between CKD and UTIs, particularly highlighting the increased vulnerability of CKD patients to MDR pathogens supported by recent studies. It also addresses the disparity in the burden of these conditions in lower-income countries where access to renal replacement therapies is limited, as illustrated by the ISN-Global Kidney Health Atlas analysis. This review emphasizes the bidirectional challenge presented by CKD, which increases the risk of significant UTIs, while UTIs can worsen kidney damage. This damaging cycle is further intensified by factors such as weakened immunity, microbiota, and rising antibiotic resistance, creating a substantial clinical issue. To effectively manage antibiotic treatment, it is necessary to transition toward a proactive, integrative strategy. Key components include early screening for CKD in high-risk populations, maintaining optimal urogenital hygiene, and implementing strong antibiotic stewardship to enhance treatment effectiveness. Additionally, this review explores promising non-antibiotic prophylactic methods, including vaccines, antimicrobial peptides, and lifestyle changes, which are critical for breaking the cycle of infection and renal decline. A comprehensive approach that incorporates preventive measures, judicious use of antimicrobials, and addressing underlying renal issues is essential for improving long-term outcomes in this vulnerable patient demographic.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.